Giulia Rotta

9PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsBiologically active moleculesNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 13, 2026
Combination with Immunocytokines Enhances the Anticancer Activity of Small Molecule Drug Conjugates and Radioligand Therapeutics Targeting Fibroblast Activation Protein.

Matilde Bocci, Laura Lucaroni, Domenico Ravazza

|Sep 30, 2025
Immunocompetent Mouse Models of Cancer Reveal the Superiority of Cellular Targets over Stromal Targets for the Development of Anticancer Bispecific Antibodies.

Stefanie K Pfister, Frauke Seehusen, Francesco Prisco

|May 11, 2025
Combinatorial treatment with upadacitinib abrogates systemic toxicity of a tumor-targeted IL-2 fusion protein.

Giulia Rotta, Eleonora Prodi, Frauke Seehusen

|Jun 17, 2024
Cytokine Biopharmaceuticals with "Activity-on-Demand" for Cancer Therapy.

Giulia Rotta, Emanuele Puca, Samuele Cazzamalli

|Apr 19, 2024
Optimizing the Design and Geometry of T Cell-Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer.

Abdullah Elsayed, Louis Plüss, Larissa Nideroest

|Mar 06, 2024
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors.

Giulia Rotta, Ettore Gilardoni, Domenico Ravazza

Pageof 2

Frequent Collaborators

5 joint publications

Sheila Dakhel Plaza

4 joint publications

Abdullah Elsayed

4 joint publications

Dario Neri

3 joint publications

Christian Pellegrino